OvaScience And Intrexon Corporation Collaborate To Accelerate Development Of Ovascience’s Ovature℠ Technology For Infertility Treatments

CAMBRIDGE, Mass. & GERMANTOWN, Md.--(BUSINESS WIRE)--OvaScience, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, and Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced an agreement to access Intrexon’s portfolio of technologies to accelerate the development of OvaScience’s OvaTure? technology platform. Separately, the companies established a Joint Venture, called OvaXon, to combine their unique technology platforms to create new applications for improving human and animal health.

Help employers find you! Check out all the jobs and post your resume.